ENTRY       D05339                      Drug
NAME        Paliperidone (JAN/USP/INN);
            Invega (TN)
PRODUCT     INVEGA (Janssen Pharmaceuticals)
  GENERIC   PALIPERIDONE (ANI Pharmaceuticals)
            PALIPERIDONE (Actavis Pharma)
            PALIPERIDONE (American Health Packaging)
            PALIPERIDONE (Amneal Pharmaceuticals LLC)
            PALIPERIDONE (Archis Pharma LLC)
            PALIPERIDONE (Ascent Pharmaceuticals)
            PALIPERIDONE (AvKARE)
            PALIPERIDONE (Lupin Pharmaceuticals)
            PALIPERIDONE (Major Pharmaceuticals)
            PALIPERIDONE (Mylan Institutional)
            PALIPERIDONE (Mylan Pharmaceuticals)
            PALIPERIDONE (NorthStar RxLLC)
            PALIPERIDONE (Patriot Pharmaceuticals)
            PALIPERIDONE (REMEDYREPACK)
            PALIPERIDONE (REMEDYREPACK)
            PALIPERIDONE (Sun Pharmaceutical Industries)
            PALIPERIDONE (Tris Pharma)
FORMULA     C23H27FN4O3
EXACT_MASS  426.2067
MOL_WEIGHT  426.4839
CLASS       Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
             DG03005  Serotonin-dopamine antagonist (SDA)
             DG03200  Antipsychotic agent
              DG03064  Atypical antipsychotic
REMARK      Same as: C21516
            Therapeutic category: 1179
            ATC code: N05AX13
            Chemical structure group: DG00907
            Product (DG00907): D05339<JP/US> D05340<JP/US>
EFFICACY    Antipsychotic, Serotonin receptor antagonist, Dopamine D2 receptor antagonist
  DISEASE   Schizophrenia [DS:H01649]
COMMENT     Serotonin-dopamine antagonists (SDA)
            Risperidone derivative
            Treatment of schizophrenia
TARGET      HTR2A [HSA:3356] [KO:K04157]
            DRD2 [HSA:1813] [KO:K04145]
  PATHWAY   hsa04080(1813+3356)  Neuroactive ligand-receptor interaction
            hsa04726(3356)  Serotonergic synapse
            hsa04728(1813)  Dopaminergic synapse
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AX Other antipsychotics
                 N05AX13 Paliperidone
                  D05339  Paliperidone (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antipsychotics
              2nd Generation/Atypical
               Paliperidone
                D05339  Paliperidone (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1179  Others
                 D05339  Paliperidone (JAN/USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00907  Paliperidone
                 D05339  Paliperidone
              DG03005  Serotonin-dopamine antagonist (SDA)
               DG00907  Paliperidone
                D05339  Paliperidone
              DG03200  Antipsychotic agent
               DG03064  Atypical antipsychotic
                DG00907  Paliperidone
                 D05339  Paliperidone
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D05339  Paliperidone (JAN/USP/INN) &lt;JP/US&gt;
               Serotonin
                HTR2A
                 D05339  Paliperidone (JAN/USP/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05339
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05339
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05339
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05339
            Prodrugs [br08324.html]
             D05339
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00907  Paliperidone
              DG03005  Serotonin-dopamine antagonist (SDA)
               DG00907  Paliperidone
              DG03200  Antipsychotic agent
               DG03064  Atypical antipsychotic
                DG00907  Paliperidone
            Prodrugs [br08324.html(DG00907)]
             DG00907
DBLINKS     CAS: 144598-75-4
            PubChem: 47207025
            ChEBI: 82978
            LigandBox: D05339
            NIKKAJI: J508.304D
ATOM        31
            1   C8y C    20.0200  -19.1800
            2   C8y C    20.0200  -17.7800
            3   N5x N    21.2100  -17.0800
            4   C8y C    22.4700  -17.7800
            5   N4y N    22.4700  -19.1800
            6   C8y C    21.2100  -19.8800
            7   C1y C    23.6600  -17.0800
            8   C1x C    24.8500  -17.7800
            9   C1x C    24.8500  -19.1800
            10  C1x C    23.6600  -19.8800
            11  O1a O    23.6600  -15.6800
            12  C1a C    18.8300  -17.0800
            13  O5x O    21.2100  -21.2800
            14  C1b C    18.8300  -19.8800
            15  C1b C    17.6400  -19.1800
            16  N1y N    16.4500  -19.8800
            17  C1x C    16.4500  -21.2800
            18  C1x C    15.2600  -21.9800
            19  C1y C    14.0700  -21.2800
            20  C1x C    14.0700  -19.8800
            21  C1x C    15.2600  -19.1800
            22  C8y C    12.8100  -21.9800
            23  N5x N    11.6753  -21.1600
            24  O2x O    10.5448  -21.9858
            25  C8y C    10.9808  -23.3162
            26  C8y C    12.3808  -23.3126
            27  C8x C    10.2839  -24.5304
            28  C8y C    10.9870  -25.7410
            29  C8x C    12.3870  -25.7375
            30  C8x C    13.0839  -24.5232
            31  X   F    10.2826  -26.9681
BOND        35
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    7  11 1
            13    2  12 1
            14    6  13 2
            15    1  14 1
            16   14  15 1
            17   15  16 1
            18   16  17 1
            19   17  18 1
            20   18  19 1
            21   19  20 1
            22   20  21 1
            23   16  21 1
            24   19  22 1
            25   22  23 2
            26   23  24 1
            27   24  25 1
            28   25  26 1
            29   22  26 1
            30   25  27 2
            31   27  28 1
            32   28  29 2
            33   29  30 1
            34   26  30 2
            35   28  31 1
///
